Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22729151)

1.

Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Uldrick TS, Polizzotto MN, Yarchoan R.

Curr Opin Oncol. 2012 Sep;24(5):495-505. doi: 10.1097/CCO.0b013e328355e0f3. Review.

PMID:
22729151
2.

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R.

Blood. 2011 Jun 30;117(26):6977-86. doi: 10.1182/blood-2010-11-317610. Epub 2011 Apr 12.

3.

KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.

Carbone A, De Paoli P, Gloghini A, Vaccher E.

Int J Cancer. 2015 Jul 15;137(2):251-61. doi: 10.1002/ijc.28923. Epub 2014 May 5. Review.

PMID:
24771491
4.

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, Wang V, Pittaluga S, O'Mahony D, Steinberg SM, Little RF, Yarchoan R.

Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.

PMID:
25331113
5.

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG.

Blood. 2001 Apr 1;97(7):2130-6. Erratum in: Blood 2001 Jun 1;97(11):3678.

6.

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.

Polizzotto MN, Uldrick TS, Hu D, Yarchoan R.

Front Microbiol. 2012 Mar 2;3:73. doi: 10.3389/fmicb.2012.00073. eCollection 2012.

7.

An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R.

Clin Infect Dis. 2010 Aug 1;51(3):350-8. doi: 10.1086/654798.

8.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V.

Blood. 2002 Apr 1;99(7):2331-6.

9.

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Whitby D.

J Infect Dis. 2012 Jun;205(11):1665-76. doi: 10.1093/infdis/jis249. Epub 2012 Mar 23.

10.

New approaches to the treatment of human herpesvirus 8-associated disease.

Casper C.

Rev Med Virol. 2008 Sep-Oct;18(5):321-9. doi: 10.1002/rmv.583. Review.

11.

Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM.

Histopathology. 2008 Nov;53(5):513-24. doi: 10.1111/j.1365-2559.2008.03144.x.

PMID:
18983461
12.

Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Venkataraman G, Uldrick TS, Aleman K, O'Mahony D, Karcher DS, Steinberg SM, Raffeld MA, Marshall V, Whitby D, Little RF, Yarchoan R, Pittaluga S, Maric I.

Am J Clin Pathol. 2013 May;139(5):651-61. doi: 10.1309/AJCPKGF7U8AWQBVG.

13.

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C.

Blood. 2001 Dec 1;98(12):3473-5.

14.

How I treat HHV8/KSHV-related diseases in posttransplant patients.

Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L.

Blood. 2012 Nov 15;120(20):4150-9. doi: 10.1182/blood-2012-04-421412. Epub 2012 Sep 11.

15.

HIV-associated multicentric Castleman disease.

Oksenhendler E.

Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. Review.

PMID:
19343828
16.

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

Wen KW, Damania B.

Cancer Lett. 2010 Mar 28;289(2):140-50. doi: 10.1016/j.canlet.2009.07.004. Epub 2009 Aug 3. Review.

17.
18.

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, Pittaluga S, O'Mahony D, Whitby D, Tosato G, Steinberg SM, Little RF, Yarchoan R.

Blood. 2013 Dec 19;122(26):4189-98. doi: 10.1182/blood-2013-08-519959. Epub 2013 Oct 30.

19.

Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Du MQ, Bacon CM, Isaacson PG.

J Clin Pathol. 2007 Dec;60(12):1350-7. Review.

20.

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.

Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST.

Leukemia. 2005 May;19(5):851-5.

PMID:
15744337
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk